Related Stories Generic semaglutide could improve diabetes treatment affordability in Canada Study explains long-term ocular symptoms following mild COVID-19 Semaglutide fuels rapid growth in US GLP-1RA use as payments rise The cumulative incidence of NAION at 36 months was 8.9% for the semaglutide cohort and 1.8% for the non-semaglutide cohort
Focusing on individuals who had been treated with semaglutide 2.4 mg for 1 year introduced a potential selection bias, as these individuals were more likely to have experienced benefits and may have demonstrated higher adherence to the medication
Its not an inflammatory condition in the traditional sense, which is part of what makes it different from arthritis or other joint diseases
2, 31-60 degrees
The most frequently reported side effects of injectable tirzepatide include: Nausea often the most common complaint, typically occurring within the first few weeks of treatment Diarrhoea loose or frequent bowel movements affecting a significant proportion of patients Vomiting may occur alongside nausea, particularly if dietary modifications are not implemented Decreased appetite whilst therapeutically beneficial for weight management, some patients find this uncomfortable Abdominal discomfort or pain ranging from mild bloating to cramping sensations Constipation paradoxically, some patients experience reduced bowel frequency Dyspepsia indigestion or upper abdominal discomfort These gastrointestinal effects result directly from the medication's mechanism of slowing gastric emptying and altering gut motility
Postmarket drug safety information for patients and providers - information for healthcare professionals: pioglitazone HCl (marketed as Actos, Actoplus Met, and Duetact)